We are live on ! Find out more
CCM

Catapult Capital Management Portfolio holdings

AUM $265M
1-Year Est. Return 21.83%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$696M
AUM Growth
-$122M
Cap. Flow
-$135M
Cap. Flow %
-19.45%
Top 10 Hldgs %
23.76%
Holding
329
New
119
Increased
34
Reduced
64
Closed
111

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$23.2M
2
PEP icon
PepsiCo
PEP
+$13.1M
3
ABBV icon
AbbVie
ABBV
+$10.1M
4
ELV icon
Elevance Health
ELV
+$9.59M
5
ABT icon
Abbott
ABT
+$8.4M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$22.4M
2
PFE icon
Pfizer
PFE
+$18M
3
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$13.1M
4
MD icon
Pediatrix Medical
MD
+$11.2M
5
DHR icon
Danaher
DHR
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 42.68%
2 Consumer Discretionary 8.46%
3 Industrials 7.26%
4 Consumer Staples 5.08%
5 Communication Services 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEE
201
DELISTED
Sealed Air
SEE
$485K 0.07%
9,430
-59,509
-86% -$2.86M
CIEN icon
202
Ciena
CIEN
$52.7B
$483K 0.07%
20,382
-7,311
-26% -$167K
SYK icon
203
Stryker
SYK
$133B
$478K 0.07%
5,000
– –
FENX
204
DELISTED
Fenix Parts, Inc.
FENX
$401K 0.06%
+40,000
New +$418K
RTX icon
205
RTX Corp
RTX
$289B
$372K 0.05%
5,334
-34,737
-87% -$2.55M
HZNP
206
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$347K 0.05%
10,000
-15,000
-60% -$458K
PVH icon
207
PVH
PVH
$4.01B
$324K 0.05%
2,812
-32,547
-92% -$3.53M
PM icon
208
Philip Morris
PM
$299B
$320K 0.05%
3,989
-39,481
-91% -$3.25M
SGNT
209
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$243K 0.03%
+10,000
New +$240K
ALSN icon
210
Allison Transmission
ALSN
$9.57B
$197K 0.03%
6,728
-92,707
-93% -$2.88M
EVHC
211
DELISTED
Envision Healthcare Holdings Inc
EVHC
$189K 0.03%
+1,598
New +$182K
AXE
212
DELISTED
Anixter International Inc
AXE
$178K 0.03%
2,734
-1,649
-38% -$117K
AERI
213
DELISTED
Aerie Pharmaceuticals
AERI
$177K 0.03%
+10,000
New +$183K
RXDX
214
DELISTED
Ignyta, Inc.
RXDX
$151K 0.02%
+10,000
New +$121K
USG
215
DELISTED
Usg
USG
$145K 0.02%
+5,204
New +$143K
MTUS icon
216
Metallus
MTUS
$826M
$90K 0.01%
+3,338
New +$98.5K
FDX icon
217
FedEx
FDX
$73B
$65K 0.01%
+379
New +$65.9K
ARRS
218
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$54K 0.01%
+1,777
New +$57.5K
AA icon
219
CALL
Alcoa
AA
$11.9B
– –
-62,422
Closed -$1.94M
A icon
220
Agilent Technologies
A
$39.2B
– –
-97,853
Closed -$4.06M
AAP icon
221
Advance Auto Parts
AAP
$3.39B
– –
-8,018
Closed -$1.2M
AEO icon
222
American Eagle Outfitters
AEO
$2.9B
– –
-30,841
Closed -$527K
ALB icon
223
CALL
Albemarle
ALB
$13.9B
– –
-80,000
Closed -$4.23M
AMAT icon
224
CALL
Applied Materials
AMAT
$398B
– –
-275,000
Closed -$6.2M
APD icon
225
Air Products & Chemicals
APD
$66.8B
– –
-57,831
Closed -$8.09M
7 8
9
10 11

Similar funds

LOCB
Lombard Odier & Cie (Bahamas) Nassau, Bahamas $263M AUM 3.37% 1-Year Est. Return
AF
Adirondack Funds Guilderland, New York $261M AUM
TCOTO
Trust Company of the Ozarks Springfield, Missouri $290M AUM 12.7% 1-Year Est. Return
DCM
Dinsmore Capital Management Morristown, New Jersey $230M AUM 0.29% 1-Year Est. Return
SCA
Samson Capital Advisors New York $228M AUM 0.84% 1-Year Est. Return
LPVHS
Lexington Partners VI Holdings Sub New York $227M AUM 24.75% 1-Year Est. Return
ATC
Argent Trust Company Ruston, Louisiana $225M AUM 5.44% 1-Year Est. Return
TFF
Timothy F. Fidgeon $203M AUM 2.36% 1-Year Est. Return

Catapult Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Catapult Capital Management held 329 positions worth $696M, down 15% from $818M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Catapult Capital Management withdrew a net $135M in Q2 2015, closing 111 positions and reducing 64 holdings. Its most notable exit was Pfizer, an estimated $18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Catapult Capital Management opened a new position in Zoetis worth $23.5M.

  • Catapult Capital Management's largest Q2 2015 buy was Zoetis: 486,665 shares worth $23.5M.
  • Catapult Capital Management added most to AbbVie in Q2 2015, an estimated $10.1M increase.
  • Catapult Capital Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $22.4M.
  • Catapult Capital Management fully exited Pfizer in Q2 2015, selling an estimated $18M.
  • Catapult Capital Management's ten largest holdings make up 24% of its $696M portfolio in Q2 2015.
  • Catapult Capital Management opened 119 new positions and closed 111 in Q2 2015.
  • Catapult Capital Management's portfolio value fell 15% quarter-over-quarter to $696M.

Based on Catapult Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.